Evidence map›Paper›PMID 23072888›Full record

ReviewNature reviews. Molecular cell biology2012

NMD: a multifaceted response to premature translational termination.

Stephanie Kervestin, Allan Jacobson

Abstract readReview
In one paragraph

Review in Nature reviews. Molecular cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 358 papers.

0numbers the graph read from it
0cells of the map it votes in
358citing papers in PubMed
27.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

358 citing papers in PubMed, 554 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Aberrant Splicing Signatures Underpin Oligodendrocyte Damage in ALS and Neuron Loss in FTD.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Ribosome Profiling for Novel Antigen Discovery.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  18. dentification and characterization of novelBMJ open diabetes research & care · 2025
    Article
  19. Article
  20. Article

298 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Stephanie KervestinCentre National de la Recherche Scientifique UPR9073, Université Paris Diderot Sorbonne Paris Cité, Institut de Biologie Physico-chimique, Paris, France.
Allan Jacobson
Sorbonne Paris Cité · FRUniversity of Massachusetts Chan Medical School · US

Funding

Messenger RNA Metabolism in YeastR37GM027757 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JACOBSON, ALLAN S · 2005 to 2014
$6.3M
MESSENGER RNA METABOLISM IN YEASTR01GM027757 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JACOBSON, ALLAN S · 1985 to 2016
$3.8M
NIGMS NIH HHS R01 GM027757NIGMS NIH HHS R37 GM027757
6 · The paper itself

Abstract

Although most mRNA molecules derived from protein-coding genes are destined to be translated into functional polypeptides, some are eliminated by cellular quality control pathways that collectively perform the task of mRNA surveillance. In the nonsense-mediated decay (NMD) pathway premature translation termination promotes the recruitment of a set of factors that destabilize a targeted mRNA. The same factors also seem to have key roles in repressing the translation of the mRNA, dissociating its terminating ribosome and messenger ribonucleoproteins (mRNPs), promoting the degradation of its truncated polypeptide product and possibly even feeding back to the site of transcription to interfere with splicing of the primary transcript.

Indexed as

Nonsense Mediated mRNA DecayCodon, NonsenseHumansPeptide Chain Termination, TranslationalPeptide Termination FactorsProtein BiosynthesisRibonucleoproteinsRibosomesRNA-Binding ProteinsRNA HelicasesRNA, MessengerRNA StabilityTrans-ActivatorsTranscription FactorsCodon, NonsensePeptide Termination FactorsRibonucleoproteinsRNA-Binding ProteinsRNA HelicasesRNA, MessengerTrans-ActivatorsTranscription FactorsUPF1 protein, humanUPF2 protein, humanUPF3A protein, human

Identifiers

PMID23072888
PMCPMC3970730
OpenAlexW2057726003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.